Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy.
Silje Watterdal SyversenIngrid JyssumAnne Therese TveterJoe SextonIngrid Egeland ChristensenTrung T TranKristin Hammersbøen BjørlykkeSiri MjaalandDavid J WarrenTore K KvienAdity ChopraGrete Birkeland KroJorgen JahnsenLudvig A MuntheEspen A HaavardsholmGunnveig GrødelandJohn Torgils VaageSella Aarrestad ProvanKristin Kaasen JørgensenGuro Løvik GollPublished in: RMD open (2022)
NCT04798625.